Summary
Twenty evaluable patients with newly diagnosed brain metastases underwent treatment with a novel dose/schedule of dexamethasone aimed at reducing steroid toxicity during palliative radiation therapy. All patients received twice daily dexamethasone starting at 8 mg bid for four days then 4 mg bid for four days then 2 mg bid until the last day of radiation therapy. The radiation prescriptions were not standardized varying from 2000 cGy/5 fractions to 5800 cGy/29 fractions. Fourteen patients received dexamethasone for a minimum of 24 hours before their first radiation treatment and 7 (50%) experienced improvement in neurologic symptoms/signs prior to starting radiation treatments. Fourteen patients completed the planned course of radiation and dexamethasone. Only 1 patient needed to restart dexamethasone within 30 days of finishing radiation because of steroid reversible neurologic deficits. Steroid toxicity was mild including hyperglycemia (1), candida esophagitis (1), steroid pseudorheumatism (2), peripheral edema (1) and steroid withdrawal syndrome (1). Only two toxic events were recorded in patients receiving steroids less than 21 days. Twice daily dexamethasone appears to provide good clinical results with minimal morbidity.
Similar content being viewed by others
References
French LA, Galicich JH: The use of steroids for control of cerebral edema. Clin Neurosurg 10: 212–223, 1964
Galicich JH, French LA: Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Practit Dig Treat 12: 169–174, 1961
Kofman S, Garvin JS, Nagamani D, Taylor SG: Treatment of cerebral metastases from breast carcinoma with prednisolone. JAMA 163: 1473–1476, 1957
Ruderman NB, Hall TC: Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 18: 298–306, 1965
Posner JB: Diagnosis and treatment of metastases to the brain. Clin Bull 4: 47–57, 1974
Weissman D, Dufer D, Vogel V, Abeloff M: Corticosteroid toxicity in neuro-oncology patients. J Neurooncol 5: 125–128, 1987
Lewis GP, Jusko WJ, Burke CW, Graves L: Prednisone side-effects and serum-protein levels. Lancet 2: 778–780, 1971
Lewis GP, Jick H, Slone D, Shapiro S: The role of genetic factors and serum protein binding in determining drug response as revealed by comprehensive drug surveillance. Ann NY Acad Sci 179: 729–738, 1971
Ehrenkranz JRL, Posner JB: Adrenocorticosteroid Hormones. In: Weiss L, Gilbert HA, Posner JB (eds) Brain Metastasis. Hall, Boston, 1980, pp 340–363
French L: The use of steroids in the treatment of cerebral edema, Bull NY Acad Med 42: 301–311, 1966
Ransohoff J: The effects of steroids on brain edema in man. In: Reulen HJ, Schurmann K (eds) Steroids and Brain Edema. Springer-Verlag, Berlin, 1972, pp 211–217
Gutin PH: Corticosteroid therapy in patients with brain tumors. Natl Cancer Inst Monogr 46: 151–156, 1977
Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529–541, 1980
Greenberg HS, Kim JH, Posner JB: Epidural spinal cord compression from metastatic epidural tumors. Mayo Clin Proc 55: 442–448, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weissman, D.E., Janjan, N.A., Erickson, B. et al. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. J Neuro-Oncol 11, 235–239 (1991). https://doi.org/10.1007/BF00165531
Issue Date:
DOI: https://doi.org/10.1007/BF00165531